BioWednesday London: Deal-making for Cell and Gene Therapy Companies

Over the last decade, cell and gene therapies have made remarkable progress, and deal-making in this space is rising rapidly. Join our panel event, hosted by Bristows, to discuss the latest opportunities and challenges involved in M&A, VC and licensing transactions in this area. The session will cover topics such as “what makes these different to deals for small molecules or other types of therapies?” and “what are the top priorities for those looking to invest in, or acquire, cell or gene therapy businesses?” The expert panel will share their valuable insights on M&A trends, lessons learnt from licensing deals, the regulatory landscape that impacts these deals, and key ingredients needed to make them a success.

Agenda

18.00 – Arrival & Networking

18.30 – Panel Discussion – Speaker details to follow…

19.30 – Networking

21.00 – Close

Refreshments will be provided during the networking.

Prices:

Members: Free

Non-members: £50 +VAT

Academics: please contact jasmin@onenucleus.com

*This button will not work if you are not logged in.